NCT00003425 2013-04-26Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectUniversity of KentuckyPhase 1/2 Completed25 enrolled
NCT00253552 2012-05-28G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisordersOHSU Knight Cancer InstitutePhase NA Terminated4 enrolled
NCT00118326 2010-05-14Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous DiseaseFred Hutchinson Cancer CenterPhase 1/2 Completed